Literature DB >> 31588429

Correlation between the serum procalcitonin level and the extension and severity of coronary artery disease in patients with non-ST-segment elevation myocardial infarction.

Seyed-Vahid Hashemipour1, Hamidreza Pourhosseini1, Ali Hosseinsabet1.   

Abstract

Research has shown correlations between some, but not all, inflammatory mediators and coronary atherosclerosis burden. Conflicting results have been reported on the correlation between the serum procalcitonin (PCT) level and the severity and extension of coronary artery disease (CAD). We evaluated the correlation between PCT and the severity and extension of CAD in patients with non-ST-elevation myocardial infarction (NSTEMI). PATIENTS AND METHODS: In this prospective cross-sectional study, the serum PCT level was measured 48 h after hospital admission in 131 patients with a diagnosis of NSTEMI. All the patients underwent selective coronary angiography, and the severity and extension of their CAD was evaluated with the Gensini score. The study population was assigned to two groups on the basis of the median of the Gensini score: those with a score higher than the median and those with a score lower than the median.
RESULTS: There was no statistically significant difference with regard to the serum PCT level between the two groups (P = 0.511). In the multivariable logistic regression analysis, after adjustment for the potential confounders, the serum PCT level was not a determinant of the Gensini score (P = 0.502).
CONCLUSION: The second 24-h postadmission serum PCT level was not correlated with the severity and extension of CAD according to the Gensini score in our patients with NSTEMI.
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Keywords:  Gensini score; coronary artery disease; myocardial infarction; procalcitonin

Year:  2019        PMID: 31588429      PMCID: PMC6738645          DOI: 10.1097/XCE.0000000000000165

Source DB:  PubMed          Journal:  Cardiovasc Endocrinol Metab        ISSN: 2574-0954


  30 in total

1.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Hugo A Katus; Bertil Lindahl; David A Morrow; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Robert O Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasché; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; José-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis
Journal:  Circulation       Date:  2012-08-24       Impact factor: 29.690

Review 2.  Techniques for phenotyping coronary artery disease in the cardiac catheterization laboratory for applications in translational research.

Authors:  Michael Ragosta
Journal:  J Cardiovasc Transl Res       Date:  2011-03-29       Impact factor: 4.132

3.  A comparison of ST elevation versus non-ST elevation myocardial infarction outcomes in a large registry database: are non-ST myocardial infarctions associated with worse long-term prognoses?

Authors:  Lech Polonski; Mariusz Gasior; Marek Gierlotka; Tadeusz Osadnik; Zbigniew Kalarus; Maria Trusz-Gluza; Marian Zembala; Krzysztof Wilczek; Andrzej Lekston; Tomasz Zdrojewski; Michal Tendera
Journal:  Int J Cardiol       Date:  2010-08-03       Impact factor: 4.164

4.  Procalcitonin as a prognostic marker in patients with acute myocardial infarction.

Authors:  Dominic Kelly; Sohail Q Khan; Onkar Dhillon; Paulene Quinn; Joachim Struck; Iain B Squire; Joan E Davies; Leong L Ng
Journal:  Biomarkers       Date:  2010-06       Impact factor: 2.658

5.  Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries.

Authors:  M Erren; H Reinecke; R Junker; M Fobker; H Schulte; J O Schurek; J Kropf; S Kerber; G Breithardt; G Assmann; P Cullen
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-10       Impact factor: 8.311

6.  Procalcitonin in acute myocardial infarction.

Authors:  Nikolaos Kafkas; Kiriaki Venetsanou; Sotirios Patsilinakos; Vasilios Voudris; Dionisios Antonatos; Kostas Kelesidis; George Baltopoulos; Peter Maniatis; Dennis V Cokkinos
Journal:  Acute Card Care       Date:  2008

Review 7.  Procalcitonin: A new biomarker for the cardiologist.

Authors:  Philipp Schuetz; Lori B Daniels; Prasad Kulkarni; Stefan D Anker; Beat Mueller
Journal:  Int J Cardiol       Date:  2016-08-11       Impact factor: 4.164

8.  The Association Between Serum Procalcitonin Levels and Severity of Coronary Artery Disease Assessed by SYNTAX Score in Patients With Acute Coronary Syndrome.

Authors:  Ahmet Göktuğ Ertem; Tolga Han Efe; Çağrı Yayla; Mehmet Kadri Akboğa; Burak Açar; Sefa Ünal; Özgür Kirbaş; Yasemin Sezer Tekce; Orhan Maden; Hatice Selcuk; Mehmet Timur Selcuk
Journal:  Angiology       Date:  2016-03-21       Impact factor: 3.619

9.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

Authors:  Marco Roffi; Carlo Patrono; Jean-Philippe Collet; Christian Mueller; Marco Valgimigli; Felicita Andreotti; Jeroen J Bax; Michael A Borger; Carlos Brotons; Derek P Chew; Baris Gencer; Gerd Hasenfuss; Keld Kjeldsen; Patrizio Lancellotti; Ulf Landmesser; Julinda Mehilli; Debabrata Mukherjee; Robert F Storey; Stephan Windecker
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

10.  Association of Clinical Factors and Therapeutic Strategies With Improvements in Survival Following Non-ST-Elevation Myocardial Infarction, 2003-2013.

Authors:  Marlous Hall; Tatendashe B Dondo; Andrew T Yan; Shaun G Goodman; Héctor Bueno; Derek P Chew; David Brieger; Adam Timmis; Phillip D Batin; John E Deanfield; Harry Hemingway; Keith A A Fox; Christopher P Gale
Journal:  JAMA       Date:  2016-09-13       Impact factor: 56.272

View more
  2 in total

1.  Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome.

Authors:  Rita Pavasini; Gioele Fabbri; Federico Marchini; Nicola Bianchi; Maria Angela Deserio; Federico Sanguettoli; Filippo Maria Verardi; Daniela Segala; Graziella Pompei; Elisabetta Tonet; Matteo Serenelli; Serena Caglioni; Gabriele Guardigli; Gianluca Campo; Rosario Cultrera
Journal:  J Clin Med       Date:  2022-01-22       Impact factor: 4.241

Review 2.  From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction.

Authors:  Cristian Stătescu; Larisa Anghel; Bogdan-Sorin Tudurachi; Andreea Leonte; Laura-Cătălina Benchea; Radu-Andy Sascău
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.